Literature DB >> 18171674

General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.

Shibing Yu1, Yu Jiang, Deborah L Galson, Min Luo, Yumei Lai, Yi Lu, Hong-Jiao Ouyang, Jian Zhang, Guozhi Xiao.   

Abstract

ATF4 (activating transcription factor 4) is an osteoblast-enriched transcription factor that regulates terminal osteoblast differentiation and bone formation. ATF4 knock-out mice have reduced bone mass (severe osteoporosis) throughout life. Runx2 (runt-related transcription factor 2) is a runt domain-containing transcription factor that is essential for bone formation during embryogenesis and postnatal life. In this study, we identified general transcription factor IIA gamma (TFIIA gamma) as a Runx2-interacting factor in a yeast two-hybrid screen. Immunoprecipitation assays confirmed that TFIIA gamma interacts with Runx2 in osteoblasts and when coexpressed in COS-7 cells or using purified glutathione S-transferase fusion proteins. Chromatin immunoprecipitation assay of MC3T3-E1 (clone MC-4) preosteoblast cells showed that in intact cells TFIIA gamma is recruited to the region of the osteocalcin promoter previously shown to bind Runx2 and ATF4. A small region of Runx2 (amino acids 258-286) was found to be required for TFIIA gamma binding. Although TFIIA gamma interacts with Runx2, it does not activate Runx2. Instead, TFIIA gamma binds to and activates ATF4. Furthermore, TFIIA gamma together with ATF4 and Runx2 stimulates osteocalcin promoter activity and endogenous mRNA expression. Small interfering RNA silencing of TFIIA gamma markedly reduces levels of endogenous ATF4 protein and Ocn mRNA in osteoblastic cells. Overexpression of TFIIA gamma increases levels of ATF4 protein. Finally, TFIIA gamma significantly prevents ATF4 degradation. This study shows that a general transcription factor, TFIIA gamma, facilitates osteoblast-specific gene expression through interactions with two important bone transcription factors ATF4 and Runx2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171674      PMCID: PMC2736298          DOI: 10.1074/jbc.M705653200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase.

Authors:  I Lassot; E Ségéral; C Berlioz-Torrent; H Durand; L Groussin; T Hai; R Benarous; F Margottin-Goguet
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation.

Authors:  Gergana Dobreva; Maria Chahrour; Marcel Dautzenberg; Laura Chirivella; Benoit Kanzler; Isabel Fariñas; Gerard Karsenty; Rudolf Grosschedl
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

Review 3.  A facelift for the general transcription factor TFIIA.

Authors:  Torill Høiby; Huiqing Zhou; Dimitra J Mitsiou; Hendrik G Stunnenberg
Journal:  Biochim Biophys Acta       Date:  2007-05-05

4.  Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.

Authors:  Chen Zhao; Naoko Irie; Yasunari Takada; Kouji Shimoda; Takeshi Miyamoto; Toru Nishiwaki; Toshio Suda; Koichi Matsuo
Journal:  Cell Metab       Date:  2006-08       Impact factor: 27.287

5.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1.

Authors:  G Xiao; D Jiang; P Thomas; M D Benson; K Guan; G Karsenty; R T Franceschi
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

Review 7.  The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis.

Authors:  T Hai; M G Hartman
Journal:  Gene       Date:  2001-07-25       Impact factor: 3.688

8.  Characterization of the upstream mouse Cbfa1/Runx2 promoter.

Authors:  Z S Xiao; S G Liu; T K Hinson; L D Quarles
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

9.  Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.

Authors:  Guozhi Xiao; Rajaram Gopalakrishnan; Di Jiang; Elizabeth Reith; M Douglas Benson; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

10.  The human androgen receptor AF1 transactivation domain: interactions with transcription factor IIF and molten-globule-like structural characteristics.

Authors:  D N Lavery; I J McEwan
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

View more
  18 in total

1.  MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice.

Authors:  Zhidan Wu; Ping Jiao; Xueming Huang; Bin Feng; Yajun Feng; Shengyong Yang; Phillip Hwang; Jing Du; Yaohui Nie; Guozhi Xiao; Haiyan Xu
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Activating transcription factor 4 regulates osteoclast differentiation in mice.

Authors:  Huiling Cao; Shibing Yu; Zhi Yao; Deborah L Galson; Yu Jiang; Xiaoyan Zhang; Jie Fan; Binfeng Lu; Youfei Guan; Min Luo; Yumei Lai; Yibei Zhu; Noriyoshi Kurihara; Kenneth Patrene; G David Roodman; Guozhi Xiao
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

3.  E2F1 effects on osteoblast differentiation and mineralization are mediated through up-regulation of frizzled-1.

Authors:  Shibing Yu; Laura M Yerges-Armstrong; Yanxia Chu; Joseph M Zmuda; Yingze Zhang
Journal:  Bone       Date:  2013-06-24       Impact factor: 4.398

4.  Runx2-interacting genes identified by yeast two-hybrid screening of libraries generated from hypertrophic chondrocytes.

Authors:  Feifei Li; Rui Mi; Chuling Fan; Ping Zhang; Ting Zhu; Qian Wang; Yaojuan Lu; Junxia Gu; Qiping Zheng
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

5.  Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis.

Authors:  Huiling Cao; Ke Zhu; Lugui Qiu; Shuai Li; Hanjie Niu; Mu Hao; Shengyong Yang; Zhongfang Zhao; Yumei Lai; Judith L Anderson; Jie Fan; Hee-Jeong Im; Di Chen; G David Roodman; Guozhi Xiao
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

Review 6.  Combinatorial control of ATF4-dependent gene transcription in osteoblasts.

Authors:  René St-Arnaud; Bahareh Hekmatnejad
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

7.  Critical role of filamin-binding LIM protein 1 (FBLP-1)/migfilin in regulation of bone remodeling.

Authors:  Guozhi Xiao; Hongqiang Cheng; Huiling Cao; Ka Chen; Yizeng Tu; Shibing Yu; Hongli Jiao; Shengyong Yang; Hee-Jeong Im; Di Chen; Ju Chen; Chuanyue Wu
Journal:  J Biol Chem       Date:  2012-05-03       Impact factor: 5.157

Review 8.  Regulation of gene expression in osteoblasts.

Authors:  Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

9.  Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.

Authors:  Jumpei Teramachi; Yuko Hiruma; Seiichi Ishizuka; Hisako Ishizuka; Jacques P Brown; Laëtitia Michou; Huiling Cao; Deborah L Galson; Mark A Subler; Hua Zhou; David W Dempster; Jolene J Windle; G David Roodman; Noriyoshi Kurihara
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

10.  Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone.

Authors:  Shibing Yu; Renny T Franceschi; Min Luo; Jie Fan; Di Jiang; Huiling Cao; Tae-Geon Kwon; Yumei Lai; Jian Zhang; Kenneth Patrene; Kurt Hankenson; G David Roodman; Guozhi Xiao
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.